$1.73 Billion in Cash—and a Strategic Recalibration
Suzano confirmed it will wire $1.73 billion in cash for its majority slice of the venture. That investment secures its hold on a restructured business designed for leaner operations, broader reach, and explosive synergy.
For Kimberly-Clark, the transaction means sharpened focus on high-margin sectors and a windfall that enables share buybacks, effectively sweetening the pot for investors. The company expects the transaction, already unanimously approved by its board, to close in mid-2026—pending regulatory review and global antitrust scrutiny.
“A Tremendous Opportunity”—Voices From the Helm
Kimberly-Clark CEO Mike Hsu called the deal “a launchpad for clarity and opportunity,” signaling a future where the company doubles down on profitability and premium markets.
Across the equator, Suzano CEO Beto Abreu hailed the fusion of “two global players” whose strengths intertwine like fibers in a sheet of premium tissue—Suzano’s industrial and operational might with Kimberly-Clark’s marketing and branding mastery.
The move also solidifies Suzano’s growing influence in the hygiene space, building upon its 2023 acquisition of Kimberly-Clark’s Brazilian tissue operations—a prelude, it turns out, to this more ambitious leap.
